Replies to post #460510 on NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

You may have a point for DCVax being too expensive a treatment for household pets, but on the point of pain, I assume it will be similar, the high QOL and low toxicity we see in humans would also apply to animals.

For broader DCVax market applications, possibly down the road, I was referring to opportunities anything related to what the immune system touches, since DCVax is the process of informing and activating DCs. This does not mean just cell mutation (i.e. cancer) but also viral infections too, because to the immune system destroying bad cells is all the same.

Considering animal health, it is maybe not a small market opportunity. Zoetis is a Pfizer owned company, $6.7B in revenue 2020. I am thinking cattle and pig health is valuable for optimizing or maximizing animal weight, survival of runts/litter, and to overall safety for consumers.

Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on 60 years of experience as Pfizer Animal Health, we discover, develop, manufacture, and commercialize quality medicines and vaccines, complemented by diagnostics products and genetics tests and supported by a range of services.

https://www.zoetis.com/about-us/zoetis-at-a-glance.aspx